Table 3.

Univariate and Multivariate Analysis for Patients with Cervical Cancer

Characteristics	N	Univariate Analysis		Multivariate Analysis
3-year OS	p	HR (95% CI)	p
Age
<65	1055	84.6%	0.014	1
≥65	139	75.1%		1.7 (1.1–2.7)	0.011
Histology
SCC	1065	84.9%	<0.001	1
Non-SCC	129	71.5%		2.3 (1.6–3.5)	<0.001
Tumor size
<4cm	477	90.3%	<0.001	1
≥4cm	717	79.0%		1.7 (1.2–2.5)	0.004
FIGO stage
I	154	90.8%	<0.001	1
II	826	85.3%		1.6 (0.8–3.1)	0.144
III	205	72.7%		2.8 (1.4–5.7)	0.003
IVA	9	21.4%		1.8 (0.5–6.9)	0.362
Mesorectum MLNs
Yes	1184	0%	<0.001	4.0 (1.8–9.1)	0.001
No	10	84.4%		1
Para-aortic MLNs
Yes	81	44.0%	<0.001	1.8 (1.1–2.8)	0.017
No	1113	86.3%		1
Pelvic MLNs
Yes	353	69.3%	<0.001	2.5 (1.7–3.7)	<0.001
No	841	89.2%		1
Common iliac MLNs
Yes	96	52.0%	<0.001	1.5 (0.95–2.3)	0.082
No	1098	86.1%		1
Bilateral pelvic MLNs
Yes	209	63.5%	<0.001	1.0 (0.7–1.6)	0.938
No	985	87.6%		1
Treatment approach
RT	177	74.4%	0.001	1
CCRT	1017	85.0%		0.6 (0.4–0.9)	0.010

Abbreviations: MLNs, metastatic lymph nodes; SCC, squamous cell carcinoma.